The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
Open accessAbstract
Pulmonary arterial hypertension (PAH) is clinically characterized by a sustained elevation in mean pulmonary artery pressure leading to significant morbidity and mortality. The disorder is typically sporadic, and in such cases the term idiopathic PAH (IPAH) is used. However, cases that occur within families (familial PAH (FPAH)) display similar clinical and histopathological features, suggesting a common etiology. Heterozygous mutations of a type II member of the TGF-beta cell signaling superfamily known as BMPR2 on chromosome 2q33 have been identified in many kindreds with FPAH, yet display both reduced penetrance and sex bias. This report presents the compilation of data for 144 distinct mutations that alter the coding sequence of the BMPR2 gene identified in 210 independent PAH subjects. This large data set characterizes the extent of sequence variation and reveals that the majority (71%) of mutations in FPAH and IPAH comprise nonsense, frameshift, and splice-site defects, and gene rearrangements. These predict premature termination of the transcript with likely loss through the process of nonsense-mediated decay (NMD). A total of 44 missense mutations were identified that substitute amino acid residues at highly conserved sites within recognized functional domains of the mature receptor. We assess this category of mutations in the context of their heterogeneous effects on cell signaling when assayed by in vitro cell-based systems. Disease-causing mutation hot-spots within BMPR2 are summarized. Taken together, these observations are likely to aid in the development of targeted mutation detection strategies relevant for patient management. Finally, we examine the age- and sex-dependent reduced penetrance of BMPR2 mutations by reviewing bmpr2 animal models and the requirement for additional genetic and/or environmental modifiers of disease. In conclusion, these data provide compelling genetic evidence that haploinsufficiency is the predominant molecular mechanism underlying disease predisposition, and support the concept of a critical threshold of signaling activity below which disease may be precipitated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Hanks, S. K., & Hunter, T. R. (1995) · PubMed · Cited by 2,518
The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1
Hanks, S. K., & Hunter, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768349 · Cited by 2,318
Primary Pulmonary Hypertension: A National Prospective Study
RICH, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., DETRE, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,039
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationLane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2000) · Nature Genetics · doi:10.1038/79226 · Cited by 1,495
Self-citationDeng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,206
Distinct endocytic pathways regulate TGF-β receptor signalling and turnover
Di Guglielmo, G. M., Le Roy, C., Goodfellow, A. F., & Wrana, J. L. (2003) · Nature Cell Biology · doi:10.1038/ncb975 · Cited by 1,151
Thomson, J. R., Machado, R. D., Pauciulo, M. W., Morgan, N. V., Humbert, M., Elliott, G. C., Ward, K., Yacoub, M., Mikhail, G., Rogers, P., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.10.741 · Cited by 732
Self-citationTrembath, R. C., Thomson, J. R., Machado, R. D., Morgan, N. V., Atkinson, C., Winship, I., Simonneau, G., Galie, N., Loyd, J. E., Humbert, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450503 · Cited by 725
Self-citationAtkinson, C., Stewart, S., Upton, P. D., Machado, R., Thomson, J. R., Trembath, R. C., & Morrell, N. W. (2002) · Circulation · doi:10.1161/01.cir.0000012754.72951.3d · Cited by 697
Self-citationAtomic structure of the MAP kinase ERK2 at 2.3 A resolution
Zhang, F., Strand, A., Robbins, D., Cobb, M. H., & Goldsmith, E. J. (1994) · Nature · doi:10.1038/367704a0 · Cited by 592
BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension
Machado, R. D., Pauciulo, M. W., Thomson, J. R., Lane, K. B., Morgan, N. V., Wheeler, L., Phillips III, J. A., Newman, J., Williams, D., Galiè, N., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316947 · Cited by 535
Self-citationMorrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
Self-citationBMP Type II Receptor Is Required for Gastrulation and Early Development of Mouse Embryos
Beppu, H., Kawabata, M., Hamamoto, T., Chytil, A., Minowa, O., Noda, T., & Miyazono, K. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9670 · Cited by 421
Yang, X., Long, L., Southwood, M., Rudarakanchana, N., Upton, P. D., Jeffery, T. K., Atkinson, C., Chen, H., Trembath, R. C., & Morrell, N. W. (2005) · Circulation Research · doi:10.1161/01.res.0000166926.54293.68 · Cited by 364
Self-citationHarrison, R. E., Flanagan, J. A., Sankelo, M., Abdalla, S. A., Rowell, J., Machado, R. D., Elliott, C. G., Robbins, I. M., Olschewski, H., McLaughlin, V, et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.12.865 · Cited by 362
Self-citationDirect signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1
Foletta, V. C., Lim, M. A., Soosairajah, J., Kelly, A. P., Stanley, E. G., Shannon, M., He, W., Das, S., Massagué, J., & Bernard, O. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212060 · Cited by 325
Yeager, M. E., Halley, G. R., Golpon, H. A., Voelkel, N. F., & Tuder, R. M. (2001) · Circulation Research · doi:10.1161/01.res.88.1.e2 · Cited by 286
Rudarakanchana, N. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.13.1517 · Cited by 271
West, J., Fagan, K., Steudel, W., Fouty, B., Lane, K., Harral, J., Hoedt-Miller, M., Tada, Y., Ozimek, J., Tuder, R., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000126047.82846.20 · Cited by 263
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
Roberts, K. E., McElroy, J. J., Wong, W. P. K., Yen, E., Widlitz, A., Barst, R. J., Knowles, J. A., & Morse, J. H. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00018604 · Cited by 262
Transforming Growth Factor-β Receptor Mutations and Pulmonary Arterial Hypertension in Childhood
Harrison, R. E., Berger, R., Haworth, S. G., Tulloh, R., Mache, C. J., Morrell, N. W., Aldred, M. A., & Trembath, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000153798.78540.87 · Cited by 241
Self-citationAldred, M. A., Vijayakrishnan, J., James, V., Soubrier, F., Gomez-Sanchez, M. A., Martensson, G., Galie, N., Manes, A., Corris, P., Simonneau, G., et al. (2006) · Human Mutation · doi:10.1002/humu.9398 · Cited by 226
Self-citationIncreased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice
Song, Y., Jones, J. E., Beppu, H., Keaney, J. F., Loscalzo, J., & Zhang, Y.-Y. (2005) · Circulation · doi:10.1161/circulationaha.104.492488 · Cited by 211
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives
Humbert, M., Deng, Z., Simonneau, G., Barst, R. J., Sitbon, O., Wolf, M., Cuervo, N., Moore, K. J., Hodge, S. E., Knowles, J. A., et al. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.01762002 · Cited by 211
Self-citationBMP signaling is required for septation of the outflow tract of the mammalian heart
Délot, E. C., Bahamonde, M. E., Zhao, M., & Lyons, K. M. (2003) · Development · doi:10.1242/dev.00181 · Cited by 208
Kawabata, M., Chytil, A., & Moses, H. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5625 · Cited by 189
Lung Biopsy Specimens in the Evaluation of Pulmonary Vascular Disease
Wagenvoort, C. A. (1980) · Chest · doi:10.1378/chest.77.5.614 · Cited by 166
Adachi-Yamada, T., Nakamura, M., Irie, K., Tomoyasu, Y., Sano, Y., Mori, E., Goto, S., Ueno, N., Nishida, Y., & Matsumoto, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2322 · Cited by 165
Choe, S., Greenwald, J., Fischer, W. H., & Vale, W. (1999) · Nature Structural Biology · doi:10.1038/4887 · Cited by 147
Runo, J. R., Vnencak‐Jones, C. L., Prince, M., Loyd, J. E., Wheeler, L. A., Robbins, I. M., Lane, K. B., Newman, J. H., Johnson, J., Nichols, W. C., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-861oc · Cited by 143
Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma
Lohmann, D. R., Brandt, B., H�pping, W., Passarge, E., & Horsthemke, B. (1994) · Human Genetics · doi:10.1007/bf00201591 · Cited by 140
Nishihara, A., Watabe, T., Imamura, T., & Miyazono, K. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0063 · Cited by 136
Machado, R. D. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg365 · Cited by 129
Self-citationBMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension
Sankelo, M., Flanagan, J. A., Machado, R. D., Harrison, R., Rudarakanchana, N., Morrell, N. W., Dixon, M., Halme, M. K., Puolijoki, H., Kere, J., et al. (2005) · Human Mutation · doi:10.1002/humu.20200 · Cited by 32
Self-citationPrimary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation
Abramowicz, M. J., Haecke, P. V., DEMEDTS, M. G., & Delcroix, M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00095303 · Cited by 28
Self-citationZhicheng, J., Lu, L., Zhiyan, H., Xiansheng, C., Yubao, Z., Yuejin, Y., & Hui, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.158 · Cited by 12
Amfepramone does not cause primary pulmonary hypertension
Sacco, G. D. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00119304 · Cited by 2
Cited by
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationAuthors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Metadata
- Authors
- Machado, R. D., Aldred, M. A., James, V., Harrison, R. E., Patel, B., Schwalbe, E. C., Gruenig, E., Janssen, B., Koehler, R., Seeger, W., Eickelberg, O., Olschewski, H., Gregory Elliott, C., Glissmeyer, E., Carlquist, J., Kim, M., Torbicki, A., Fijalkowska, A., Szewczyk, G., Parma, J., Abramowicz, M. J., Galie, N., Morisaki, H., Kyotani, S., Nakanishi, N., Morisaki, T., Humbert, M., Simonneau, G., Sitbon, O., Soubrier, F., Coulet, F., Morrell, N. W., & Trembath, R. C.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2006-02
- Volume
- 27
- Issue
- 2
- Pages
- 121-132
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W1998123371
- Cited by
- 402
- References
- 40
- FWCI
- 24.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.